Skip to search.
 FTSE 100 Down 0.15%

Sangamo Biosciences Inc. (SGMO)

-NasdaqGS
4.93 Up 0.07(1.44%) 27 Sep 21:00
|After Hours: : 4.93 0.00 (0.00%) 27 Sep 22:58
Prev Close:4.86
Open:4.86
Bid:4.78 x 1000
Ask:5.90 x 100
1y Target Est:15.25
Beta:2.92819
Earnings Date:26 Oct - 31 Oct (Est.)
Day's Range:4.83 - 5.06
52wk Range:4.08 - 9.91
Volume:688,176
Avg Vol (3m):899,734
Market Cap:348.15m
P/E (ttm):N/A
EPS (ttm):-0.94
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for SGMO at this time.

Comparison

Symbol% ChgMkt Cap
SGMOUp 1.44%348.15m
LLYUp 1.71%85.35b
AMGNDown 1.09%128.44b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.11
Quarterly EPS Est (Sep-16) :-0.25
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Sangamo BioSciences, Inc., a clinical stage biopharmaceutical company, focuses on the research, development, and commercialization of engineered DNA-binding proteins for therapeutic genome editing and gene regulation. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback